Akouos Inc. raised $50 million in a tranched series A financing co-led by 5AM Ventures and New Enterprise Associates (NEA), which first committed to the newly formed gene therapy firm in a $7.6 million seed round in November 2017. Existing seed investor Partners Innovation Fund and new investors Sofinnova Ventures, RA Capital Management and Novartis Venture Fund joined the series A.